SmartCella, Sweden
Biotechnology Engineer specializing in cell and gene therapy CMC, with a track record of leading teams developing scalable and affordable manufacturing solutions for allogeneic cell therapies. Contributed to cellular immunotherapies and pluripotent stem cell–based therapies at organizations like CCRM, Cell and Gene Therapy Catapult, Cellectis, Alder Therapeutics and Procella Therapeutics. His recent work includes the design of GMP-compliant manufacturing facilities at SmartCella. Strategically focused on bridging scientific discovery and commercial manufacturing, Ricardo serves on Advisory Boards and ISSCR’s steering committee for Best Practices of PSC-derived therapies. He holds a PhD in Biochemical Engineering and completed postdoctoral research at Peter Zandstra's Stem Cell Bioengineering Lab.
BEST PRACTICES FOR THE TRANSLATION OF PLURIPOTENT STEM CELL-DERIVED THERAPIES
Thursday, June 12, 2025
8:30 AM – 10:00 AM HK Time
MANUFACTURING WITH COMMERCIALIZATION IN MIND
Friday, June 13, 2025
8:30 AM – 10:00 AM HK Time
MANUFACTURING OF STEM CELL THERAPIES WITH COMMERCIALISATION IN MIND
Friday, June 13, 2025
8:30 AM – 10:00 AM HK Time